Is Inhibikase Therapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: IKT) stock is to Buy IKT stock.
Out of 1 analyst, 0 (0%) are recommending IKT as a Strong Buy, 1 (100%) are recommending IKT as a Buy, 0 (0%) are recommending IKT as a Hold, 0 (0%) are recommending IKT as a Sell, and 0 (0%) are recommending IKT as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year IKT price target, the average IKT price target is $27.00, with the highest IKT stock price forecast at $27.00 and the lowest IKT stock price forecast at $27.00.
The Wall Street analyst predicted that Inhibikase Therapeutics's share price could reach $27.00 by Mar 7, 2025. The average Inhibikase Therapeutics stock price prediction forecasts a potential upside of 1,185.71% from the current IKT share price of $2.10.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.